Equifax stock price target lowered to $278 by UBS on mixed outlook

Published 23/07/2025, 15:58
Equifax stock price target lowered to $278 by UBS on mixed outlook

Investing.com - UBS lowered its price target on Equifax (NYSE:EFX) to $278.00 from $315.00 on Wednesday, while maintaining a Buy rating on the stock. According to InvestingPro data, the company currently trades at a P/E ratio of 47.1x and commands a market capitalization of $30.27 billion.

The credit reporting company’s shares fell approximately 7% following the announcement, exceeding the implied 4.5% move, as disappointing third-quarter guidance and foreign exchange-induced 2025 outlook adjustments overshadowed second-quarter earnings beat. InvestingPro analysis indicates the stock is currently in oversold territory based on RSI readings, with shares down over 8% in the past week.

Equifax Workforce Solutions (EWS), which represents about 45% of company revenue, saw revenue growth accelerate by 500 basis points to 8% year-over-year, driven by government and consumer lending growth. However, full-year EWS guidance was reduced by 200 basis points to approximately 5% year-over-year due to weaker I-9 and onboarding revenue following slower hiring in July amid corporate caution.

The company increased its U.S. Information Solutions (USIS) 2025 growth forecast by 200 basis points to approximately 7%, partially driven by mortgage revenue outperformance of 20% year-over-year despite no change in mortgage market outlook. Equifax also reported share gains in pre-qualification and pre-approval products.

UBS cited an uncertain macroeconomic environment and elevated earnings volatility as reasons for the price target reduction, while acknowledging Equifax’s strong free cash flow and $190 million in capital return during the second quarter, which included $127 million in share buybacks and $62 million in dividends. Notably, InvestingPro data shows the company has maintained dividend payments for 55 consecutive years, with a current dividend yield of 0.84% and impressive gross profit margins of 56.44%. For deeper insights into Equifax’s valuation and financial health metrics, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.

In other recent news, Equifax Inc . reported its highest-ever quarterly revenue for the second quarter of 2025, with earnings per share reaching $1.53, surpassing the forecast of $1.50. The company achieved a revenue of $1.54 billion, exceeding expectations by 1.99%, and noted ongoing growth in its Workforce Solutions and International segments. Despite these positive financial results, shares saw a decline of 5.65% in pre-market trading, indicating mixed investor sentiment. Additionally, Stifel has reiterated its Buy rating on Equifax stock, maintaining a price target of $295. The firm expressed some disappointment regarding the pace of government sales but remains optimistic that Equifax will eventually secure these deals. These developments highlight recent activities and assessments concerning Equifax.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.